{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T22:20:58Z","timestamp":1792189258124,"version":"4.4.0"},"reference-count":55,"publisher":"The Endocrine Society","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,12,1]]},"abstract":"<jats:p>Endometriosis is a chronic inflammatory disease of reproductive age women leading to chronic pelvic pain and infertility. Current antiestrogen therapies are temporizing measures, and endometriosis often recurs. Potential nonestrogenic or nonsteroidal targets are needed for treating endometriosis. Peroxisome proliferator-activated receptor (PPAR)\u03b3, a nuclear receptor, is activated by thiazolidinediones (TZDs). In experimental endometriosis, TZDs inhibit growth of endometriosis. Clinical data suggest potential use of TZDs for treating pain and fertility concurrently in endometriosis patients. Study objectives were to 1) determine the effects of PPAR\u03b3 action on growth and survival of human endometriotic epithelial and stromal cells and 2) identify the underlying molecular links between PPAR\u03b3 activation and cell cycle regulation, apoptosis, estrogen biosynthesis, and prostaglandin E2 biosynthesis and signaling in human endometriotic epithelial and stromal cells. Results indicate that activation of PPAR\u03b3 by TZD ciglitazone 1) inhibits growth of endometriotic epithelial cells 12Z up to 35% and growth of endometriotic stromal cells 22B up to 70% through altered cell cycle regulation and intrinsic apoptosis, 2) decreases expression of PGE2 receptors (EP)2 and EP4 mRNAs in 12Z and 22B cells, and 3) inhibits expression and function of P450 aromatase mRNA and protein and estrone production in 12Z and 22B cells through EP2 and EP4 in a stromal-epithelial cell-specific manner. Collectively, these results indicate that PGE2 receptors EP2 and EP4 mediate actions of PPAR\u03b3 by incorporating multiple cell signaling pathways. Activation of PPAR\u03b3 combined with inhibition of EP2 and EP4 may emerge as novel nonsteroidal therapeutic targets for endometriosis-associated pain and infertility, if clinically proven safe and efficacious.<\/jats:p>","DOI":"10.1210\/en.2013-1168","type":"journal-article","created":{"date-parts":[[2013,9,25]],"date-time":"2013-09-25T09:39:51Z","timestamp":1380101991000},"page":"4803-4813","source":"Crossref","is-referenced-by-count":33,"title":["PPAR\u03b3 Activation Inhibits Growth and Survival of Human Endometriotic Cells by Suppressing Estrogen Biosynthesis and PGE2 Signaling."],"prefix":"10.1210","volume":"154","author":[{"given":"Dan I.","family":"Lebovic","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology (D.I.L.), Division of Reproductive Endocrinology and Infertility, University of Wisconsin, Madison, Wisconsin 53562"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahryar K.","family":"Kavoussi","sequence":"first","affiliation":[{"name":"Austin Fertility & Reproductive Medicine\/Westlake IVF (S.K.K.), Austin, Texas 78746"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JeHoon","family":"Lee","sequence":"first","affiliation":[{"name":"Reproductive Endocrinology and Cell Signaling Laboratory (J.L., S.K.B., J.A.A.), Department of Integrative Biosciences, College of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, Texas 77843"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakhila K.","family":"Banu","sequence":"first","affiliation":[{"name":"Reproductive Endocrinology and Cell Signaling Laboratory (J.L., S.K.B., J.A.A.), Department of Integrative Biosciences, College of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, Texas 77843"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joe A.","family":"Arosh","sequence":"first","affiliation":[{"name":"Reproductive Endocrinology and Cell Signaling Laboratory (J.L., S.K.B., J.A.A.), Department of Integrative Biosciences, College of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, Texas 77843"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"2020071612443370700_B1","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1172\/JCI11705","article-title":"Unraveling the mechanism of action of thiazolidinediones","volume":"106","author":"Kahn","year":"2000","journal-title":"J Clin Invest"},{"key":"2020071612443370700_B2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1462399405008793","article-title":"PPAR \u03b3 as a metabolic regulator: insights from genomics and pharmacology","volume":"7","author":"Savage","year":"2005","journal-title":"Expert Rev Mol Med"},{"key":"2020071612443370700_B3","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1172\/JCI28003","article-title":"PPAR \u03b3 and human metabolic disease","volume":"116","author":"Semple","year":"2006","journal-title":"J Clin Invest"},{"key":"2020071612443370700_B4","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1146\/annurev.biochem.77.061307.091829","article-title":"Fat and beyond: the diverse biology of PPAR\u03b3","volume":"77","author":"Tontonoz","year":"2008","journal-title":"Annu Rev Biochem"},{"key":"2020071612443370700_B5","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0015-0282(02)04835-5","article-title":"Cytokine regulation by peroxisome proliferator-activated receptor \u03b3 in human endometrial cells","volume":"79","author":"Wanichkul","year":"2003","journal-title":"Fertil Steril"},{"key":"2020071612443370700_B6","first-page":"1841","article-title":"PPAR-\u03b3 decreases endometrial stromal cell transcription and translation of RANTES in vitro","volume":"87","author":"Pritts","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612443370700_B7","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1517\/13543784.15.9.1039","article-title":"The potential of antidiabetic thiazolidinediones for anticancer therapy","volume":"15","author":"Galli","year":"2006","journal-title":"Expert Opin Investig Drugs"},{"key":"2020071612443370700_B8","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1517\/13543784.2012.683783","article-title":"New trends for the medical treatment of endometriosis","volume":"21","author":"Rocha","year":"2012","journal-title":"Expert Opin Investig Drugs"},{"key":"2020071612443370700_B9","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1159\/000068952","article-title":"Thiazolidinedione inhibition of peritoneal inflammation","volume":"55","author":"Hornung","year":"2003","journal-title":"Gynecol Obstet Invest"},{"key":"2020071612443370700_B10","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1517\/13543784.16.10.1561","article-title":"Peroxisome proliferator-activated receptor-\u03b3 ligands as investigational modulators of angiogenesis","volume":"16","author":"Giaginis","year":"2007","journal-title":"Expert Opin Investig Drugs"},{"key":"2020071612443370700_B11","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1056\/NEJMra0804690","article-title":"Endometriosis","volume":"360","author":"Bulun","year":"2009","journal-title":"N Engl J Med"},{"key":"2020071612443370700_B12","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/S0140-6736(04)17403-5","article-title":"Endometriosis","volume":"364","author":"Giudice","year":"2004","journal-title":"Lancet"},{"key":"2020071612443370700_B13","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1097\/AOG.0b013e31822adfd1","article-title":"Clinical management of endometriosis","volume":"118","author":"Falcone","year":"2011","journal-title":"Obstet Gynecol"},{"key":"2020071612443370700_B14","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1159\/000098413","article-title":"Two unsuccessful clinical trials on endometriosis and a few lessons learned","volume":"64","author":"Guo","year":"2007","journal-title":"Gynecol Obstet Invest"},{"key":"2020071612443370700_B15","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.2174\/092986708784049595","article-title":"Non-steroidal targets in the diagnosis and treatment of endometriosis","volume":"15","author":"Kyama","year":"2008","journal-title":"Curr Med Chem"},{"key":"2020071612443370700_B16","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.fertnstert.2011.05.063","article-title":"The inhibitory effect of celecoxib and rosiglitazone on experimental endometriosis","volume":"96","author":"Olivares","year":"2011","journal-title":"Fertil Steril"},{"key":"2020071612443370700_B17","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1479-828X.2007.00744.x","article-title":"Peroxisome proliferator-activated receptor-\u03b3 agonist rosiglitazone reduces the size of experimental endometriosis in the rat model","volume":"47","author":"Aytan","year":"2007","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"2020071612443370700_B18","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jsgi.2005.10.002","article-title":"Effect of peroxisome proliferator-activated receptor-\u03b3 agonist rosiglitazone on the induction of endometriosis in an experimental rat model","volume":"13","author":"Demirturk","year":"2006","journal-title":"J Soc Gynecol Investig"},{"key":"2020071612443370700_B19","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.fertnstert.2004.02.148","article-title":"Peroxisome proliferator-activated receptor-\u03b3 induces regression of endometrial explants in a rat model of endometriosis","volume":"82","author":"Lebovic","year":"2004","journal-title":"Fertil Steril"},{"key":"2020071612443370700_B20","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/j.fertnstert.2010.09.017","article-title":"Development and prevention of postsurgical adhesions in a chimeric mouse model of experimental endometriosis","volume":"95","author":"Herington","year":"2011","journal-title":"Fertil Steril"},{"key":"2020071612443370700_B21","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.fertnstert.2006.12.072","article-title":"PPAR-\u03b3 receptor ligand induces regression of endometrial explants in baboons: a prospective, randomized, placebo- and drug-controlled study","volume":"88","author":"Lebovic","year":"2007","journal-title":"Fertil Steril"},{"key":"2020071612443370700_B22","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1210\/en.2009-1076","article-title":"Peroxisome proliferator-activated receptor-(\u03b3) receptor ligand partially prevents the development of endometrial explants in baboons: a prospective, randomized, placebo-controlled study","volume":"151","author":"Lebovic","year":"2010","journal-title":"Endocrinology"},{"key":"2020071612443370700_B23","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s10456-005-9027-4","article-title":"PPAR \u03b3 represses VEGF expression in human endometrial cells: implications for uterine angiogenesis","volume":"8","author":"Peeters","year":"2005","journal-title":"Angiogenesis"},{"key":"2020071612443370700_B24","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.fertnstert.2010.09.008","article-title":"In vitro effects of peroxisome proliferator-activated receptor-\u03b3 ligands on gene expression in lipopolysaccharide-induced endometrial and endometriotic stromal cells","volume":"95","author":"Sharma","year":"2011","journal-title":"Fertil Steril"},{"key":"2020071612443370700_B25","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1517\/14728214.2012.668885","article-title":"New treatment strategies and emerging drugs in endometriosis","volume":"17","author":"Streuli","year":"2012","journal-title":"Expert Opin Emerg Drugs"},{"key":"2020071612443370700_B26","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000230713","article-title":"Thiazolidinediones as therapy for endometriosis: a case series","volume":"68","author":"Moravek","year":"2009","journal-title":"Gynecol Obstet Invest"},{"key":"2020071612443370700_B27","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1210\/jc.2008-1180","article-title":"Prostaglandin E2 via steroidogenic factor-1 coordinately regulates transcription of steroidogenic genes necessary for estrogen synthesis in endometriosis","volume":"94","author":"Attar","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612443370700_B28","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1055\/s-2004-823026","article-title":"Aromatase and endometriosis","volume":"22","author":"Bulun","year":"2004","journal-title":"Semin Reprod Med"},{"key":"2020071612443370700_B29","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1749-6632.2002.tb02767.x","article-title":"Estrogen production and metabolism in endometriosis","volume":"955","author":"Bulun","year":"2002","journal-title":"Ann NY Acad Sci"},{"key":"2020071612443370700_B30","doi-asserted-by":"crossref","first-page":"3433","DOI":"10.1074\/jbc.M705409200","article-title":"EP2 and EP4 receptors regulate aromatase expression in human adipocytes and breast cancer cells. Evidence of a BRCA1 and p300 exchange","volume":"283","author":"Subbaramaiah","year":"2008","journal-title":"J Biol Chem"},{"key":"2020071612443370700_B31","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1158\/1940-6207.CAPR-12-0201","article-title":"Pioglitazone, a PPAR\u03b3 agonist, suppresses CYP19 transcription: evidence for involvement of 15-hydroxyprostaglandin dehydrogenase and BRCA1","volume":"5","author":"Subbaramaiah","year":"2012","journal-title":"Cancer Prev Res (Phila)"},{"key":"2020071612443370700_B32","first-page":"1604","article-title":"Peroxisome proliferator-activated receptor \u03b3 ligands inhibit estrogen biosynthesis in human breast adipose tissue: possible implications for breast cancer therapy","volume":"60","author":"Rubin","year":"2000","journal-title":"Cancer Res"},{"key":"2020071612443370700_B33","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1006\/bbrc.2000.2701","article-title":"Insulin sensitizer, troglitazone, directly inhibits aromatase activity in human ovarian granulosa cells","volume":"271","author":"Mu","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"2020071612443370700_B34","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1210\/en.2004-1046","article-title":"Activation of peroxisome proliferator-activated receptor-\u03b3 and retinoid X receptor inhibits aromatase transcription via nuclear factor-\u03baB","volume":"146","author":"Fan","year":"2005","journal-title":"Endocrinology"},{"key":"2020071612443370700_B35","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1210\/en.2007-1087","article-title":"Molecular cloning and characterization of prostaglandin transporter in ovine endometrium: role of mitogen activated protein kinase pathways in release of prostaglandin F2 \u03b1","volume":"149","author":"Banu","year":"2008","journal-title":"Enodcrinology"},{"key":"2020071612443370700_B36","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1210\/me.2009-0017","article-title":"Selective inhibition of prostaglandin E2 receptors EP2 and EP4 induces apoptosis of human endometriotic cells through suppression of ERK1\/2, AKT, NF\u03baB and b-catenin pathways and activation of intrinsic apoptotic mechanisms","volume":"23","author":"Banu","year":"2009","journal-title":"Mol Endocrinol"},{"key":"2020071612443370700_B37","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1016\/j.fertnstert.2010.01.038","article-title":"Selective blockade of prostaglandin E2 receptors EP2 and EP4 signaling inhibits proliferation of human endometriotic epithelial cells and stromal cells through distinct cell cycle arrest","volume":"93","author":"Lee","year":"2010","journal-title":"Fertil Steril"},{"key":"2020071612443370700_B38","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1258\/ebm.2010.009321","article-title":"Prostaglandin E2: the master of endometriosis?","volume":"235","author":"Wu","year":"2010","journal-title":"Exp Biol Med (Maywood)"},{"key":"2020071612443370700_B39","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1016\/S0002-9440(10)63030-1","article-title":"Identification of an invasive, N-cadherin-expressing epithelial cell type in endometriosis using a new cell culture model","volume":"159","author":"Zeitvogel","year":"2001","journal-title":"Am J Pathol"},{"key":"2020071612443370700_B40","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1177\/1933719107302913","article-title":"Trichostatin A, a histone deacetylase inhibitor, attenuates invasiveness and reactivates E-cadherin expression in immortalized endometriotic cells","volume":"14","author":"Wu","year":"2007","journal-title":"Reprod Sci"},{"key":"2020071612443370700_B41","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.mce.2010.11.022","article-title":"Selective inhibition of prostaglandin E2 receptors EP2 and EP4 inhibits invasion of human immortalized endometriotic epithelial and stromal cells through suppression of metalloproteinases","volume":"332","author":"Lee","year":"2011","journal-title":"Mol Cell Endocrinol"},{"key":"2020071612443370700_B42","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1016\/j.fertnstert.2008.06.050","article-title":"Induction of peritoneal endometriosis in nude mice with use of human immortalized endometriosis epithelial and stromal cells: a potential experimental tool to study molecular pathogenesis of endometriosis in humans","volume":"91","author":"Banu","year":"2009","journal-title":"Fertil Steril"},{"key":"2020071612443370700_B43","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1210\/en.2007-1168","article-title":"Cyclooxygenase-2 regulates survival, migration, and invasion of human endometriotic cells through multiple mechanisms","volume":"149","author":"Banu","year":"2008","journal-title":"Endocrinology"},{"key":"2020071612443370700_B44","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.fertnstert.2007.07.1358","article-title":"Gene expression profiles and functional characterization of human immortalized endometriotic epithelial and stromal cells","volume":"90","author":"Banu","year":"2008","journal-title":"Fertil Steril"},{"key":"2020071612443370700_B45","first-page":"205","article-title":"International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes","volume":"46","author":"Coleman","year":"1994","journal-title":"Pharmacol Rev"},{"key":"2020071612443370700_B46","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/0006-2952(95)02035-7","article-title":"6-Isopropoxy-9-oxoxanthene-2-carboxylic acid (AH 6809), a human EP2 receptor antagonist","volume":"50","author":"Woodward","year":"1995","journal-title":"Biochem Pharmacol"},{"key":"2020071612443370700_B47","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1054\/plef.1999.0120","article-title":"Endogenous EP4 prostaglandin receptors coupled positively to adenylyl cyclase in Chinese hamster ovary cells: pharmacological characterization","volume":"62","author":"Crider","year":"2000","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"2020071612443370700_B48","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal Biochem"},{"key":"2020071612443370700_B49","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0303-7207(97)00128-7","article-title":"IFN-tau increases PGE2 production and COX-2 gene expression in the bovine endometrium in vitro","volume":"132","author":"Asselin","year":"1997","journal-title":"Mol Cell Endocrinol"},{"key":"2020071612443370700_B50","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1146\/annurev.pharmtox.39.1.295","article-title":"Cyclins and cell cycle checkpoints","volume":"39","author":"Johnson","year":"1999","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"2020071612443370700_B51","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.tibs.2005.09.005","article-title":"Mammalian cyclin-dependent kinases","volume":"30","author":"Malumbres","year":"2005","journal-title":"Trends Biochem Sci"},{"key":"2020071612443370700_B52","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.semcdb.2005.02.007","article-title":"New insights into cyclins, CDKs, and cell cycle control","volume":"16","author":"S\u00e1nchez","year":"2005","journal-title":"Semin Cell Dev Biol"},{"key":"2020071612443370700_B53","doi-asserted-by":"crossref","first-page":"9408","DOI":"10.1200\/JCO.2005.01.5594","article-title":"Targeting the cell cycle: a new approach to cancer therapy","volume":"23","author":"Schwartz","year":"2005","journal-title":"J Clin Oncol"},{"key":"2020071612443370700_B54","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/sj.onc.1210220","article-title":"The Bcl-2 apoptotic switch in cancer development and therapy","volume":"26","author":"Adams","year":"2007","journal-title":"Oncogene"},{"key":"2020071612443370700_B55","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1146\/annurev.biochem.73.011303.073706","article-title":"Cytochrome C-mediated apoptosis","volume":"73","author":"Jiang","year":"2004","journal-title":"Annu Rev Biochem"}],"container-title":["Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/154\/12\/4803\/13636254\/endo4803.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/154\/12\/4803\/13636254\/endo4803.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T21:44:32Z","timestamp":1594935872000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/endo\/article\/154\/12\/4803\/2433362"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12,1]]},"references-count":55,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2013,12,1]]}},"URL":"https:\/\/doi.org\/10.1210\/en.2013-1168","relation":{},"ISSN":["0013-7227","1945-7170"],"issn-type":[{"value":"0013-7227","type":"print"},{"value":"1945-7170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12,1]]}}}